Metformin as an Anti-Aging Drug: The Claims Versus the Trial Data
Biohackers take metformin to slow aging, but the trial designed to actually prove that, TAME, still has not finished enrolling.
May 6, 2024

Search
60 stories for“slow design”
Biohackers take metformin to slow aging, but the trial designed to actually prove that, TAME, still has not finished enrolling.
May 6, 2024

Forty-one volunteers who breathed with a long exhale accepted riskier bets for money in an MRI scanner, and those whose heart rhythm responded most showed the strongest reward activity in the brain. A neat result, a small sample, a lesson about calm.
Sep 8, 2026

Mantra recitation across several religious traditions converges on a slow, sustained, vocalised exhalation. That is also the single breathing pattern with the best evidence for shifting the autonomic nervous system.
Sep 4, 2026

Rentosertib was built to treat pulmonary fibrosis. In 42 patients, blood proteins read by six independent clocks came out three to four years younger after a month. Independent doctors say a younger score is not a younger person.
Sep 15, 2026

Tirzepatide just earned an approval that has nothing to do with the scale. Here is what SELECT, FLOW and the new sleep apnea data show.
Jan 8, 2025

A Cochrane review of twenty-one trials found yoga probably better than no exercise for chronic low back pain, with small improvements. Emergency department data shows injury rates rising, most steeply among people over sixty-five.
Sep 4, 2026

A delayed mortality count reveals the June heatwave’s true scale, showing why the deadliest climate disaster can pass quietly behind ordinary causes of death.
Jul 23, 2026

SGLT2 inhibitors were developed to lower blood sugar by making you urinate it out. The glucose effect turned out to be the least interesting thing about them, and the kidney trials changed how this complication is treated.
Jul 25, 2026

GLP-1 receptor agonists did not start as weight loss drugs. Here is the biology behind Ozempic, Mounjaro and the hormone they mimic.
Jan 25, 2024

Trial data on stopping semaglutide shows most of the lost weight comes back within a year. Here is what the STEP 1 extension found.
May 15, 2024

A phase 1 trial at the Charite in Berlin used CD19 CAR T cells, a treatment built for blood cancers, on patients who had already failed between five and eight biologic drugs. Disease activity fell in every one of them. Three reached medication free remission.
Aug 30, 2026

Retatrutide just posted phase 3 weight loss data hitting three hormone receptors at once. Here is what is confirmed and what remains unproven.
May 27, 2026
